MTD - Mettler-Toledo misses Q4 top-line and bottom-line estimates; initiates Q1 and FY24 outlook
2024-02-08 17:03:43 ET
More on Mettler-Toledo
- Mettler-Toledo's 2023 Dip Exposes An Opportunity To Acquire This Compounder At A Discount
- Mettler-Toledo: Weak Chinese Pharma And Biopharma Continues To FY24
- Mettler-Toledo International lowers Q4 sales guidance on unexpected shipping delays
- Seeking Alpha’s Quant Rating on Mettler-Toledo